PUMA β Antibodies

Santa Cruz Biotechnology provides a broad selection of PUMA β monoclonal antibodies for research focused on understanding PUMA's role in cellular processes. PUMA β monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PUMA (p53 upregulated modulator of apoptosis) is a pro-apoptotic protein that plays a critical role in the regulation of programmed cell death, particularly in response to cellular stress and DNA damage. By promoting apoptosis, PUMA is essential for maintaining cellular homeostasis and preventing the proliferation of damaged cells, which can lead to cancer. Understanding PUMA β function is vital for developing therapeutic strategies targeting apoptosis in various diseases. PUMA β research has revealed significant insights into cancer development and potential treatment approaches. Ongoing studies continue to uncover new aspects of PUMA β's involvement in cellular pathways and disease mechanisms. Research utilizing PUMA β monoclonal antibodies has enhanced our understanding of apoptotic processes in both normal and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies for PUMA β support researchers worldwide in advancing scientific knowledge of apoptosis regulation and cancer biology.